“医药分开”如何落地?全国人大代表丁小兵支招

2019-03-05 刘璋景、黄京 华声在线

当前,药品流通业发展取得巨大成就,但药品生产流通秩序混乱现象始终没有得到很好解决,药品价格虚高尚未根治。3月4日,全国人大代表、华润集团湖南区域工委书记、华润集团驻湖南省首席代表丁小兵建议,落实“医药分开”,彻底破除“以药补医”,需要坚持医保、医药、医疗“三医联动”,协调推进医疗价格、人事薪酬、药品流通、医保支付方式等改革。“以药养医”一直是医改当中难以攻克的难关,到底怎样落实“医药分开”?丁小兵

当前,药品流通业发展取得巨大成就,但药品生产流通秩序混乱现象始终没有得到很好解决,药品价格虚高尚未根治。3月4日,全国人大代表、华润集团湖南区域工委书记、华润集团驻湖南省首席代表丁小兵建议,落实“医药分开”,彻底破除“以药补医”,需要坚持医保、医药、医疗“三医联动”,协调推进医疗价格、人事薪酬、药品流通、医保支付方式等改革。

“以药养医”一直是医改当中难以攻克的难关,到底怎样落实“医药分开”?丁小兵认为,药不养医,政府就要加大对医院的投入;药不养医,就要提高医疗技术或诊断的价格。

首先要加大政府的财政投入,让医院尽快回归其公益性质的本位。政府财政对医院基本建设、大型设备购置等进行专项补助,并将财政补助与医院绩效考核挂钩。“医院服务量越大、绩效考核越好,获得补偿和奖励也就越多。建议适当放宽民营资本和外资进入医院。”

其次,提高增加医生的挂号费、诊疗费等“医事服务费”,体现医生的专业价值,扭转医院“以药养医”的困境。应引入第三方机构,加强对医生处方行为的监督。强化患者的消费主体地位,如出现过度医疗或诱导购药行为,消费者应及时上报相关部门,有效切断医院、药房、药商等各方的利益链接。

此外,要坚持医保、医药、医疗“三医联动”,协调推进医疗价格、人事薪酬、药品流通、医保支付方式等改革。要加快落实基本药物制度,让药品招投标制落到实处,确立药价形成机制,规范药品定价程序,健全并严格执行药品审批程序规定和注册的技术标准规定;整顿药品流通秩序,改进药品采购管理,而不是走过场。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1914095, encodeId=ccda191409541, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Sun Dec 15 19:54:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774969, encodeId=f7ac1e74969f0, content=<a href='/topic/show?id=17135e073b5' target=_blank style='color:#2F92EE;'>#支招#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57073, encryptionId=17135e073b5, topicName=支招)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21738724507, createdName=psybestwish, createdTime=Sun Mar 31 07:54:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409809, encodeId=9e911409809a6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 07 13:54:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534920, encodeId=3169153492078, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Thu Mar 07 13:54:00 CST 2019, time=2019-03-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1914095, encodeId=ccda191409541, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Sun Dec 15 19:54:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774969, encodeId=f7ac1e74969f0, content=<a href='/topic/show?id=17135e073b5' target=_blank style='color:#2F92EE;'>#支招#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57073, encryptionId=17135e073b5, topicName=支招)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21738724507, createdName=psybestwish, createdTime=Sun Mar 31 07:54:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409809, encodeId=9e911409809a6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 07 13:54:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534920, encodeId=3169153492078, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Thu Mar 07 13:54:00 CST 2019, time=2019-03-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1914095, encodeId=ccda191409541, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Sun Dec 15 19:54:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774969, encodeId=f7ac1e74969f0, content=<a href='/topic/show?id=17135e073b5' target=_blank style='color:#2F92EE;'>#支招#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57073, encryptionId=17135e073b5, topicName=支招)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21738724507, createdName=psybestwish, createdTime=Sun Mar 31 07:54:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409809, encodeId=9e911409809a6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 07 13:54:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534920, encodeId=3169153492078, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Thu Mar 07 13:54:00 CST 2019, time=2019-03-07, status=1, ipAttribution=)]
    2019-03-07 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1914095, encodeId=ccda191409541, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Sun Dec 15 19:54:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774969, encodeId=f7ac1e74969f0, content=<a href='/topic/show?id=17135e073b5' target=_blank style='color:#2F92EE;'>#支招#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57073, encryptionId=17135e073b5, topicName=支招)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21738724507, createdName=psybestwish, createdTime=Sun Mar 31 07:54:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409809, encodeId=9e911409809a6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Mar 07 13:54:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534920, encodeId=3169153492078, content=<a href='/topic/show?id=10123528e63' target=_blank style='color:#2F92EE;'>#医药分开#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35287, encryptionId=10123528e63, topicName=医药分开)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=202612558221, createdName=zhishijing, createdTime=Thu Mar 07 13:54:00 CST 2019, time=2019-03-07, status=1, ipAttribution=)]

相关资讯

处方外流正式落地!医院内外药品同规同价

广东省第二人民医院率先开通处方流转平台服务。

聊聊“医药分开”那些事儿

自2009年以来,“医药分开”一直是医改的核心内容之一。近年来,为了探索“医药分开”的有效途径,各地陆续推出了“药房托管”、门诊药房剥离、取消门诊药房等改革探索。然而,“医药分开”推行了二十余年,始终不及预期。

从医药分开到医保结算 京津冀吉辽晒医改好经验

12月22日,国家卫生健康委员会在北京召开新闻发布会。会上,北京市卫生健康委主任雷海潮、北京市西城区政府副区长郁治、天津市蓟州区政府副区长王俊茹、河北省黄骅市政府市长宋忠秋、辽宁省辽阳市政府副市长原阳、吉林省白城市政府副市长梁仰椿分别介绍各地有关深化医改工作的典型经验。北京医药分开综合改革成效显着“2017年3月,北京市政府印发《医药分开综合改革实施方案》,改革实施以来,迈出坚实步伐,发生积极

药房托管被叫停!这么大个市场是要彻底凉凉了……

继上海、湖北等省市叫停药房托管后,江苏省卫生健康委员会也下发文件,明确禁止药房托管。

“医”和“药”是不是一定得分开?

说到“医药分开”这个词,它到底是什么,其实在概念上从来没有界定。

京津冀地区:剑指控费 一砍再砍!降价15% 每年节省8亿元!

京津冀医用耗材联合采购来了,跟吗?